Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS)

CUSIP: 92859E207

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
6,713,803
Total 13F shares
245,048
Share change
+58,152
Total reported value
$630,697
Price per share
$2.61
Number of holders
22
Value change
+$156,010
Number of buys
11
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 92859E207?
CUSIP 92859E207 identifies VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) as of Q3 2024

As of 30 Sep 2024, Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 245,048 shares. The largest 10 holders included Strategic Wealth Investment Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, OMERS ADMINISTRATION Corp, COMMONWEALTH EQUITY SERVICES, LLC, SABBY MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Credit Agricole S A, and Tower Research Capital LLC (TRC). This page lists 22 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.